CLINICAL_TRIALS trial_result · 2013-12-24

Clinical Trial Update: Milnacipran (Savella) in Irritable Bowel Syndrome (IBS) [Phase 2]

A Phase 2 trial of milnacipran (Savella) for irritable bowel syndrome was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Spencer Dorn, MD, MPH | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2013-12-24